ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,392,687 | +10.5% | 2,741,086 | +45.5% | 0.02% | +4.8% |
| Q1 2023 | $16,637,839 | +344083.7% | 1,884,240 | +197.8% | 0.02% | +200.0% |
| Q4 2022 | $4,834 | -99.9% | 632,728 | +33.5% | 0.01% | +40.0% |
| Q3 2022 | $3,375,000 | +41.2% | 474,033 | +60.5% | 0.01% | +66.7% |
| Q2 2022 | $2,390,000 | +18.6% | 295,382 | +103.4% | 0.00% | +50.0% |
| Q1 2022 | $2,016,000 | -50.5% | 145,228 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $4,075,000 | -79.2% | 145,228 | -74.8% | 0.00% | -81.8% |
| Q3 2021 | $19,602,000 | – | 576,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |